Why Novo Nordisk’s CEO has learned to trust his gut feeling Podcast Por  arte de portada

Why Novo Nordisk’s CEO has learned to trust his gut feeling

Why Novo Nordisk’s CEO has learned to trust his gut feeling

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.

Todavía no hay opiniones